Results 11 to 20 of about 6,565 (207)

Continuous Subcutaneous Insulin Infusion (CSII) in Inpatient Setting: Unmet Needs and the Proposal of a CSII Unit

Diabetes Technology & Therapeutics, 2011
Continuous subcutaneous insulin infusion (CSII) represents an increasingly popular method of treating diabetes. Patients with diabetes are often hospitalized, and current data indicate that inpatient hyperglycemia results in poorer outcomes. When patients on insulin pump therapy require hospitalization, practitioners caring for them face the issue of ...
Morviducci, L, Di Flaviani, A, Lauria, A, Pitocco, D, POZZILLI, PAOLO, Suraci, C, FRONTONI, SIMONA, CSII Study Group Of Lazio Region, I.t.a.l.y. Collaborators: Cappa, M, Patera, IP, Manfrini, S, Bracaglia, D, Ciampittiello, G, Cicconetti, E, Ventura, C, Bloise, D, Tatti, P, Leotta, S, Visalli, N, Caputo, S, Ghirlanda, G, Giaccari, A, Cavallo, GM, Leonetti, F, LAURO, DAVIDE, MANCA BITTI, MARIA LUISA, MARINI, MARIA ADELAIDE, SPALLONE, VINCENZA, Napoli, A, Pugliese, G, Nardone, MR, Tubili, C, Giuliano, M, Fava, D, Piergiovanni, F, Forte, E, Tuccinardi, F, Chiaramonte, F, Buzzetti, R, Leto, G.   +40 more
openaire   +7 more sources

Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation [PDF]

Health Technology Assessment, 2010
Background: The National Institute for Health and Clinical Excellence (NICE) was reviewing its previous guidance on continuous subcutaneous insulin infusion (CSII). The review provided an assessment of evidence which had been published since the previous
E Cummins, P Royle, A Snaith, A Greene, L Robertson, L McIntyre, N Waugh   +6 more
doaj   +2 more sources

Self monitoring of blood glucose in CSII-treated adolescents with type 1 diabetes

, 2008
Many diabetic clinics in Sweden recommend four self monitoring of blood glucose (SMBG) per day for CSII treated adolescents, however it is common that CSII treated adolescents with type 1 diabetes perform fewer SMBG than recommended.Objectives: To ...
Lindholm Olinder, Anna,
core   +7 more sources

Clinical characteristics and in-hospital mortality among insulin pump users with acute coronary syndrome in the predominantly open-loop era: A UK-wide MINAP registry analysis. [PDF]

Diabet Med
Abstract Background We compared characteristics of adults with insulin‐treated diabetes using continuous subcutaneous insulin infusion (CSII) versus multiple daily insulin injections (MDI) during admission with acute coronary syndrome (ACS) and identified factors associated with in‐hospital mortality among CSII users.
Deshmukh H, Shaikh M, Wilmot EG, Kilpatrick E, Chattopadhyay S, Sathyapalan T, John J.   +6 more
europepmc   +2 more sources

Experiences and decision making during paediatric transitions to continuous sub-cutaneous insulin infusion (CSII): A mixed method study

Digital Health, 2018
Objectives We aimed to improve the decision quality and outcomes for families with children or adolescents with diabetes considering continuous sub-cutaneous insulin infusion (CSII).
Erika Altmann, Christine Stirling, Liz Broad   +2 more
doaj   +2 more sources

Continuous Intraperitoneal Insulin Infusion for People With Type 1 Diabetes: A Literature Review and International Position Statement. [PDF]

Diabetes Obes Metab
ABSTRACT Achieving glucose targets without hypoglycaemia is the treatment goal in type 1 diabetes. Structured education, intensified insulin injection regimens, continuous glucose monitoring, automated insulin delivery, and ongoing support from a multidisciplinary team all support people with type 1 diabetes to achieve this goal. Despite these advances,
Oliver N, Gehr B, Lal R, van Dijk PR, Renard E.   +4 more
europepmc   +2 more sources

Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes [PDF]

, 2004
Objectives: To assess the clinical and cost-effectiveness of continuous subcutaneous insulin infusion (CSII) compared with multiple daily injections (MDI) in the delivery of intensive insulin therapy for the treatment of diabetes mellitus.
Green, C., N Waugh, Waugh, Norman, M Sidhu, D Hartwell, Colquitt, J. L. (Jill L.), Hartwell, D. (Debbie L.), C Green, J Colquitt, Sidhu, M. K.   +9 more
core   +1 more source

Hyperkalaemia after interruption of CSII [PDF]

Diabetologia, 1986
Reprise de certains resultats d'une etude de 1982 sur les dangers de l'arret de l'infusion continue sous-cutane d ...
openaire   +2 more sources

Subcutaneous insulin infusion (CSII) in italy: The third national survey

, 2015
Continuous subcutaneous insulin infusion (CSII) is increasingly being used worldwide, mostly thanks to technical improvements. This study examined the current status of CSII in Italy. Physicians in charge of 272 diabetes centers caring for patients using
Tercelj K., Gentile S., Massafra C., Candido R., Malandrucco I., Chebat E., Duratorre E., Chiaramonte F., Bordone C., Tommaselli L., Michelini M., Cipriano P., Guido R., Di Benedetto A., Graziano F. M., Pissarelli A., Lombardi S., Gatti A., Moramarco F., Veronelli A., Bonato V., Bollati P. M., Dagani R., Faloia E., Cirillo A., Coracina A., Scarpitta A. M., Aiello A., Bonomo M., Cherubini V., Delvecchio M., Fongher C., Massimiani F., La Penna G., Scalpone R., Fattor B., Moscatiello S., Iannilli A., Sabbion A., Romanelli T., Rotondo E., Girelli A., Tuccinardi F., Pianta A., Bonfanti R., Gottero C., Giunta L., Reinstadler P., Russo V., Pugliese G., Zanette G., Bocchini S., Maggi D., Cavani R., Marelli G., Cossu E., Baroni M., Marafetti L., Mingardi R., Lera R., Vespasiani G., Contin M. L., Panebianco G., Marangoni A., Di Cianni G., Vitacolonna E., Garofalo M. R., Tosini D., Lazzaro N., Romano S., Comici A., Richini D., Corsi A., Serra R., Forlani G., Fornengo R., Taraborrelli M., Mileti G., Ricciardi G. P., Di Perna P., Savastio S., Coccioli M. S., Negri C., Zanfardino A., Napoli A., Cipponeri E., Antenucci D., Melis M., Guarino G., Bozzetto L., Esposito K., Santinelli C., Ali A., Rabini R. A., Chiavetta A., Franzetti I., Calderini M. C., Moretti C., Braione A. F., Cimicchi M. C., Macerala B., Parmigiani S., Miola M., Lo Presti D., Bulgheroni M., Maurizi A. R., Dei Cas A., Gastaldi L., Lucchesi S., Colleluori P., Amarri S., Fava D., Vilei V., Mozzillo E., Soldani C., Cadario F., Monesi M., Tornese G., Alfidi P., Rauch S., De Berardinis F., Sparasci G., Cappa M., Grosso J., Ventura C., De Bernardinis M., Costa S., Grassi G., Riboni S., Di Bartolo P., Sternari G., De Donno V., Visalli N., Tonutti L., Frontoni S., Kaufmann P., Papagno G., De Cosmo S., Fabbri F., Monciotti C. M., Frontino G., Bonacina M., Galetta M., Ghisoni G., Micale F., Pagliani U., Cazzaniga E., Lapolla A., Foglia A., Suraci C., Salzano G., Cavallo L., Vitale C., Maltoni G., Ghilardi G., Boemi M., Tomasi F., Rosolen A., Mesturino C. A., Dall'Aglio E., Romeo F., Arcano S., Bucciarelli L., Barbieri P., Misischi I., Rocca A., Morano S., Maolo G., Speranza D., Lesina A., Giraudo F., Acquati S., Morviducci L., Zecchino C., Querci F., Muratori M., Bianchi A., Vitale A., Falasca P., Vedovato M., Mecca N., Schettino M., Cambuli V. M., Gallo F., Predieri B., Inversini C., Lombardo F., Roppolo R., Bruzzese M., Manca E., Leto G., Secco A., Prandi E., Livolsi P., Colapinto P., Scotton R., Ciucci A., Zanatta M., Beltrami C., Zappa A., Trevisan R., Tubili C., Giorda C., Moro E., Ospedale S. C., Annuzzi G., Gargiulo P., Forte E., Lisato G., Leopardi A., Rabbone I., Cauvin V., Maffeis C., Terni T., Busciantella Ricci N., Arico C. N., Calcaterra F., Leonetti F., Torlone E., Di Secli C., Bertaina S., Provenzano V., Lambiase C., Bensa M., Faleschini E., Nogara A., Savino T., Pitocco D., Giovanni S., Marino A., Felappi B., Brunato B., Zavaroni D., D'Amato L., Rossi E., Leotta S., Strollo F., Eisath J., Paciotti V., De Morelli G., Mammi F., Lalli C., Assaloni R., Toni S., Ugolotti D., Di Blasi V., Cordera R., Strazzabosco M., Di Masa P., Toscanella F., Papi M., Corigliano M., Tortul C., Petrucco A., Petrizzo M., Bechaz M., Giorgino F., Ponzani P., Scaramuzza A., Tardio S. M., Tumminia A., Parillo M., Guasti G., Marsciani A., Bobbio A., Origlia C., Migliorini S., Orsi E., Manca-Bitti M. L., Ragonese M., Piccinno E., Aglialoro A., Lovati E., Manicardi V., Fuso V., Ciampittiello G., Zucchini S., Briatore L., Guerraggio L., Elli P., Del Prato S., Scarponi M., Fochesato E., Arnaldi C., Calvo G., Lamacchia O., Ortolani F., Manti R., Lamanna C., Laviola L., Galderisi A., Chiambretti A. M., Mangone I., Molinari C., Sambataro M., Agus S., Zuccotti G. V., Crino A., Tesei A. M., Locatelli F., Tommasi E., Cipolloni L., Zavaroni I., Ruggeri P., Nieri S., De Luca A., Bondesan L., Mandosi E., Bonfadini S., Timpanaro T. A., Laurenzi A., Frison V., Fleres M., Di Vieste G., Pasquino B., Norgiolini R., Volpi A., Cardella F., Degiovanni M., Minnucci A., Giuliano M., Milli B., Rossi C., Dalfra M. G., Bertuzzi F., Iughetti L., Songini M., Di Vincenzo S., Stefanelli G., Montani V., Bossi A. C., Franceschi R., Palmacci C., Berra C., Nizzoli M., Meneghini E., Maghenzani G., Siri M., Bassi V., Torchio G., Fresa R., Sciangula L., Buono P., Tumini S., Incelli G., Fontana F., Toscano V., Cosma A., Rauseo A., Aragona M., Santoro E., Mollo F., Citriniti F., Paccagnella A., Pellicano F., Manfrini S., Mannucci E., Citro G., Lenzi L., Iafusco D., Celleno R., Irace C., Lapolla R., Zonca S., Scattoni R., Cartechini M. G., Corigliano G., Tinti D., Chierici G., Pozzilli P., Boscaro M., Di Caro P., Musacchio N., De Feo E., Vianello S., Lauro D., Patrone M., Cicconetti E., Alagona C., Schiaffini R., Marini M. A., Palmieri E., Trombetta M., Bruttomesso D., Cavallo M. G., Lepore G., Berzi D., Confortin L., Bettio M., Portogruaro S., Picca G., Gnasso A., Suprani T., Buzzetti R., Gallarotti F., Lasagni A., Nardone M. R., Zanon M., Carrai E., Bolli G. B., Minuto N., Zecchini B., Tinti G., Massucco P., Sabato D., Guidoni G. L., Carro S., Pedini A., Romano I., Morea A., Boscolo B. A.   +410 more
core   +4 more sources

Effects of Liraglutide Combined with Short-Term Continuous Subcutaneous Insulin Infusion on Glycemic Control and Beta Cell Function in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A Pilot Study

Journal of Diabetes Research, 2016
The objective of this paper is to investigate the effects of liraglutide in combination with short-term continuous subcutaneous insulin infusion (CSII) therapy on glycemic control and beta cell function in patients with newly diagnosed type 2 diabetes ...
Weijian Ke, Liehua Liu, Juan Liu, Ailing Chen, Wanping Deng, Pengyuan Zhang, Xiaopei Cao, Zhihong Liao, Haipeng Xiao, Jianbin Liu, Yanbing Li   +10 more
doaj   +1 more source